Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reckitt’s Schiff Buy Reflects Nutritional Industry “On Fire”

This article was originally published in The Tan Sheet

Executive Summary

Reckitt Benckiser went high with its $1.4 billion bid for Schiff Nutrition, though the acquisition’s impressive multiples are not entirely out of line with earlier deals in the nutrition space. Analyst Damian Witkowski notes that Airborne, MegaRed and other Schiff brands already are primed for organic growth.

You may also be interested in...



Cognitive Conditions Fueling Demand For Dietary Ingredient Breakthroughs

Rising rates of Alzheimer’s disease and other cognitive conditions fuel demand for brain health supplements among consumers, with more than a third of US consumers saying they would be “very likely” to take them for memory, according to research firm Natural Marketing Institute.

Victoria's Family Takes Pre-emptive Shot At Airborne Trade Dress Litigation

Pine Brothers, founded by the creator of the Airborne immune supplement brand now owned by Reckitt, files a complaint in California federal court asking for an order to find packaging for its Victoria’s Family Formula does not infringe trade dress of Airborne, as Reckitt alleges in a cease and desist letter.

Schiff Supplements, MJN Formulas, Other Reckitt Benckiser Consumer Brands Get Their Own Home

UK manufacturer in January begins operating with a separate health care division, representing 60% of sales with products including Schiff supplements and Mead Johnson infant and adult formulas, and a home care/hygiene division led by Lysol disinfectants. The plan piques analysts' expectations that operating the divisions separately will lead to divesting one.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS106110

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel